NCT02655588

Brief Summary

The primary purpose of this study is to examine how much change in depressive symptoms will be observed in persons who use an electronic Problem Solving Treatment (imbPST) compared to a control group at pre-, mid-point, and post-test assessments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Sep 2014

Typical duration for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 5, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 14, 2016

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2016

Completed
Last Updated

March 14, 2017

Status Verified

March 1, 2017

Enrollment Period

2.1 years

First QC Date

January 5, 2016

Last Update Submit

March 10, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Symptoms of Depression will be assessed by using the Beck Depression Inventory II

    Self-report measure for symptoms of depression

    Within the first 9 weeks after initiating treatment.

Secondary Outcomes (2)

  • Software usability will be measured by the System Usability Scale

    at baseline (week 0),and post-treatment ( week 9)

  • Symptoms of Depression will be assessed by using the Hopkins Symptom Checklist 20-item Depression Scale ( Self-report)

    Within the first 9 weeks after initiating treatment.

Study Arms (2)

ImbPST

EXPERIMENTAL

ImbPST Arm: Participants in this arm will interact with imbPST program which provides a simulated therapy session based on the Problem Solving Treatment-Primary Care (PST-PC) treatment manual used in depression clinical trials . imbPST via a "virtual" therapist (presented via audio and video) provides programmed instructions on the steps and skills of problem solving, emotional support, and tailored feedback to the user's input.

Behavioral: Interactive Media-Based Problems Solving Treatment

Control Group

NO INTERVENTION

Control Arm: Participants in this group will not receive any treatment for their depression and their depressive symptoms will be monitored for 6 to 9 weeks

Interventions

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be 18 years of age or older.
  • Present symptoms from the following criteria based on the Diagnostic \& Statistical Manual of Mental Disorders-IV-Text Revision (DSM-IV-TR): Major Depressive Episode, Mood Disorder Due to a General Medical Condition and/or Adjustment Disorder with Depressed Mood.
  • Not receiving psychological treatment (e.g., face to face) at the time of the study.
  • Not currently be receiving Problem Solving Treatment in any other context.
  • Not reporting/reported suicidal attempts in the year prior to their participation in the study.
  • Be able to write and speak English according to Rapid Estimate of Adult Literacy in Medicine (REALM test scores)

You may not qualify if:

  • Current suicidal ideation, history of suicidal attempts or self-injurious behavior at any point during the protocol.
  • Have been diagnosed with schizophrenia, bipolar I disorder, with psychosis, other disorder with psychotic symptoms, and/or brain injuries that includes loss of consciousness \> 15 minutes and / post-traumatic amnesia of any duration.
  • Any history of treatment with anti-psychotic medication.
  • A felony conviction.
  • Any current or recent (i.e. within the previous 6 months) substance abuse/dependence diagnosis (other than nicotine or caffeine).
  • Current psychological treatment (e.g., face to face).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beth Israel Deconess Medical Center

Boston, Massachusetts, 02130, United States

Location

Related Publications (9)

  • Arnau RC, Meagher MW, Norris MP, Bramson R. Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients. Health Psychol. 2001 Mar;20(2):112-9. doi: 10.1037//0278-6133.20.2.112.

    PMID: 11315728BACKGROUND
  • Hegel, M.T., & Arean, P.A. (2003) Problem-solving Treatment for Primary Care (PST-PC): A Treatment Manual for Depression

    BACKGROUND
  • Munoz RF, Cuijpers P, Smit F, Barrera AZ, Leykin Y. Prevention of major depression. Annu Rev Clin Psychol. 2010;6:181-212. doi: 10.1146/annurev-clinpsy-033109-132040.

    PMID: 20192789BACKGROUND
  • Proudfoot J, Goldberg D, Mann A, Everitt B, Marks I, Gray JA. Computerized, interactive, multimedia cognitive-behavioural program for anxiety and depression in general practice. Psychol Med. 2003 Feb;33(2):217-27. doi: 10.1017/s0033291702007225.

    PMID: 12622301BACKGROUND
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.

    PMID: 11556941BACKGROUND
  • Heinzelmann PJ, Lugn NE, Kvedar JC. Telemedicine in the future. J Telemed Telecare. 2005;11(8):384-90. doi: 10.1177/1357633X0501100802.

    PMID: 16356311BACKGROUND
  • Beck, A.T., Steer, R.A., & Garbin, M.C. (1988).Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review

    BACKGROUND
  • Lipman RS, Covi L, Shapiro AK. The Hopkins Symptom Checklist (HSCL)--factors derived from the HSCL-90. J Affect Disord. 1979 Mar;1(1):9-24. doi: 10.1016/0165-0327(79)90021-1.

    PMID: 162184BACKGROUND
  • Thornett AM, Mynors-Wallis LM. Credibility of problem-solving therapy and medication for the treatment of depression among primary care patients. Med Sci Monit. 2002 Mar;8(3):CR193-6.

    PMID: 11887035BACKGROUND

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • William Stone, Ph.D.

    Beth Israel Deaconess Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 5, 2016

First Posted

January 14, 2016

Study Start

September 1, 2014

Primary Completion

October 20, 2016

Study Completion

October 20, 2016

Last Updated

March 14, 2017

Record last verified: 2017-03

Locations